tuberculosis: key issues for ipac

48
Tuberculosis: key issues for IPAC Dr Elizabeth Rea AMOH, Toronto Public Health June, 2018 IPAC-SWO Chapter

Upload: others

Post on 01-Oct-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Tuberculosis: key issues for IPAC

Tuberculosis: key issues for IPAC Dr Elizabeth Rea AMOH, Toronto Public Health

June, 2018

IPAC-SWO Chapter

Page 2: Tuberculosis: key issues for IPAC

Objectives

No conflicts of interest to declare

Basics of TB, and infectiousness

IPAC issues in hospital and leaving

hospital

Contact investigation and occ health

follow-up

Page 3: Tuberculosis: key issues for IPAC

TB in Ontario, or why this is worth

paying attention to

600+ cases/yr

Most TB in GTA, but

increasingly occurring

across Ontario as

immigration widens

Immunocompromised

patients,

international students

Hospitals with 200+ beds:

high risk =

6+ TB cases per year

Page 4: Tuberculosis: key issues for IPAC

TB 101: a slow illness

• Slow-growing bacteria

• Serious illness – but preventable, treatable, curable

• Treatment is 6+ months of special antibiotics

• TB in the lungs is infectious

• only 10% of people who get infected will get sick… months or years later

•TB care and medication is free to patient in Ontario

Page 5: Tuberculosis: key issues for IPAC

TB clinical presentation

•New or worsening cough 2+ weeks

•Fever, night sweats

•Fatigue

•Anorexia

•Weight loss

•Hemoptysis

•1/3 Extra-pulmonary: varies with site

Page 6: Tuberculosis: key issues for IPAC

High-risk groups

High risk of exposure (infection, LTBI): born in TB-endemic country

- Refugee camps

native Canadians on / from northern reserve or Arctic

- shelter system; jail?

High risk of progression to active disease: contact of active TB in last 2 years

recent immigration (2-5 years)

immunocompromised (HIV, ca, elderly, diabetes, babies, malnutrition, alcoholic…)

- homeless

Page 7: Tuberculosis: key issues for IPAC

The Global TB epidemic

•¼ of all humans

infected with TB

Page 8: Tuberculosis: key issues for IPAC

Global TB Rates

http://www.who.int/tb/publications/global_report/en/

Page 9: Tuberculosis: key issues for IPAC

Diagnostic testing for TB

•CXR or CT

•Sputum x3 (or biopsy) for TB:

–AFB smear (24 hours), PCR (48 hrs) and

culture(1-4 weeks)

–Drug sensitivities – all first line (1-2 more

weeks)

Page 10: Tuberculosis: key issues for IPAC
Page 11: Tuberculosis: key issues for IPAC

TB Infection Vs. TB Disease

TB Infection (LTBI) (Not Active-Latent)

• +ve skin test

• not infectious • no symptoms • bacteria=dormant • normal CXR • medicine - optional

TB Disease (Active-replicating)

• +ve skin test

• infectious in lungs • symptomatic • bacteria=multiplying • abnormal CXR • must take medicine

Page 12: Tuberculosis: key issues for IPAC

TB has a lot of baggage

• many people remember when

TB was hard to cure – many have

relatives who were very ill or died

TB can be scary

• many cultures link TB and

“being dirty” or poor TB can feel

shameful, not a respectable

illness

• TB is spread through the air it

can feel like you don’t have

control

Page 13: Tuberculosis: key issues for IPAC

Hospital TB in the news…

Page 14: Tuberculosis: key issues for IPAC

Hospital TB in the news…

Page 15: Tuberculosis: key issues for IPAC

Pop quiz

Is this patient infectious?

Page 16: Tuberculosis: key issues for IPAC

Infectiousness

Only respiratory TB

contagious

TB is NOT exquisitely

infectious

Close, prolonged contact

Smear (AFB) +ve

Cavitary

Coughing

Young children rarely

infectious

Page 17: Tuberculosis: key issues for IPAC

IPAC and TB

72 yr old man immigrated from India 10 years ago,

4 week history of fever, cough, SOB, anorexia, 5

kg weight loss.

Clinician concerned about TB

Do not wait for lab results!

Airborne isolation

pending work-up

Page 18: Tuberculosis: key issues for IPAC

• Sputum smear negative (2-3 sputum samples)

• Alternate diagnosis (TB ruled out)

OR if TB diagnosed:

• Sputum smear negative (2-3 samples)

• On adequate TB meds at least 2 weeks

• Drug sensitivities known

• Clinical improvement

Criteria to d/c airborne precautions

Page 19: Tuberculosis: key issues for IPAC

Discharge Planning

19 year old international student from Korea with

extensive cavitary smear 4+ pulmonary TB.

Unwell, but stable on standard TB x 24 hours.

Anxious to get out of hospital – his insurance

doesn’t cover TB (“pre-existing condition”)

Can he go home?

Page 20: Tuberculosis: key issues for IPAC

• Clinically well enough!

• Public health notified (home environment assessed, meds, DOT)

• Follow-up plan

• If home environment safe, do NOT have to be non-infectious to d/c

• Discharge to LTC or other congregate settings: MUST be non-infectious

• If infectious: do not put on public transit to get home!

Discharging home

Page 21: Tuberculosis: key issues for IPAC

Ensure all TB patients get good TB care and complete treatment, minimize further transmission, make it easier to do the right thing

TB is reportable, so that:

All TB meds free through public health

Every patient with active TB has a public health nurse

Case management

discharge planning, isolation while infectious

education / support for patients, families

DOT (directly observed therapy)

Working with difficult situations, legal aspects

TB-UP (outpatient care if no OHIP)

Contact tracing

Public Health TB Care

Page 22: Tuberculosis: key issues for IPAC

Home isolation

Page 23: Tuberculosis: key issues for IPAC

• Provincial TB-UP program covers all TB diagnostics, physician billing, and TB meds for patients with no insurance and unable to pay

• Access through local public health unit

• TB diagnosis does not have to be confirmed already – will cover the work-up

• Does not cover in-patient bed fee

TB – no health insurance ?!

Page 24: Tuberculosis: key issues for IPAC

Contact Tracing Objectives

• Identify and screen contacts at risk of infection

• Isolate and Initiate treatment for secondary cases

• Offer preventive treatment to contacts with latent TB infection (LTBI)

• Identify and fix gaps in infection control, policy, practice

…but who to screen?

Page 25: Tuberculosis: key issues for IPAC

Breaking the chain

Exposure to

infectious case

Susceptible

host Infectious case

Susceptible

host

Exposure to

infectious case Infectious case

- Early detection of secondary cases

(1%)

- Detection and treatment of (new) LTBI

Page 26: Tuberculosis: key issues for IPAC

TB Contact Follow-up

approach

1. Risk assessment - define contacts

2. Identify specific contacts

3. Find contacts

4. Test/screen contacts Treat those who are ill or infected

5. Review results: expand contact follow-up?

6. Identify and fix gaps in infection control, policy, practice

Page 27: Tuberculosis: key issues for IPAC

Risk Assessment for TB

exposure

environment

Setting(s)

people

Infectiousness of index case

Duration of exposure

Page 28: Tuberculosis: key issues for IPAC

Hospital considerations

• Congregate setting where outbreaks can occur

• Patients at higher risk of becoming infected due to

illnesses or immunocompromising medical/surgical

interventions

• Responsibilities re staff exposures – risk to staff,

future risk to patients

• LTBI treatment often not possible for patient contacts – and very low uptake among staff contacts

• Large number of patients, staff, visitors – without a

structured systematic approach can easily become

huge, unfocused, and ineffective

Page 29: Tuberculosis: key issues for IPAC

Variable hospital exposure

variables!

• Wide range of ventilation 2-30 ACH

• Variable types/intensity of exposures - unique

procedure exposures, intensive personal care,

etc

• Variable baseline TB programs (IPAC and Occ

Health)

Contact investigation works best if adapted

thoughtfully to specific hospital settings, exposure

events, and information – eg measured air

exchange in TB exposure locations

Page 30: Tuberculosis: key issues for IPAC

Nosocomial Transmission

• no nosocomial transmission over 5 year evaluation period in

Toronto (487 patient contacts evaluated)

• since 2007, two nosocomial secondary cases among patient

contacts, both confirmed on TB strain genotyping

• Highly infectious index cases

(cavitary, smear 4+)

• Significantly immunosuppressed

roommates

• Shared 6 and 16 nights in the same

room with index

Page 31: Tuberculosis: key issues for IPAC

Staff exposure

• since 2007, 3 nosocomial TB transmissions to staff in

Toronto that we know of (there may be more!)

• all involved airway management of an unsuspected smear

positive pulmonary TB patient

• One documented converter became secondary case –

genotype match to index case

very few acquire TB at work, but non-zero risk!

Page 32: Tuberculosis: key issues for IPAC

HCWs are people too

• People with active TB in Toronto include nurses, doctors, dentists, physiotherapists…6% are HCW

•Almost all acquired TB in country of origin – like most other TB cases in Toronto

Page 33: Tuberculosis: key issues for IPAC

Toronto’s New and Improved Tool for Initial TB Contact Investigation (contact parameters tool v3.0)

Page 34: Tuberculosis: key issues for IPAC

What is the CSPT?

• Developed and evaluated in the Toronto context

• Evidence-based operational tool

• Consistent, systematic approach

• Puts parameters on hours of exposure

• Minimum guidelines for initial investigation

The Contact Screening Parameters Tool (CSPT) is an operational, risk-based approach for prioritizing contact follow-up for infectious tuberculosis cases

Page 35: Tuberculosis: key issues for IPAC

• Contact follow-up decision making is an iterative process

• Always consider the specific circumstances, work from first principles, and re-evaluate outcomes to adapt (as needed)

What the CSPT is NOT

CSPT is NOT a recipe book!

Page 36: Tuberculosis: key issues for IPAC

CSPT: An Evolution

2007 - 2016 2005 – 2007

2016 Validation study

Can we improve on the concentric circle

approach and prioritize contact follow-up better?

Is the CSPT working? Can we improve

the tool?

Page 37: Tuberculosis: key issues for IPAC

• 960 Pulmonary TB cases, June 2007 to May 2012

• 6,428 Contacts identified according to CSPT

• iPHIS, Contact Investigation Line Lists, Genotyping/OUT-TB through to 2014

• Literature review

06/05/2014

SITE SCREENED

Case Manager Case managers use only

Index Case Resp AMTD : Date Case Reported :

Name

Date of Birth (mm/dd/yyyy)

iPHIS ID# Revised 2011.01.041615778

Contact name, iPHIS

ID#

Relation-

ship to

Case

(coded)

DOB

mm/dd/yyyy

Eligible

for

follow-up

(coded)

Last date of

exposure

mm/dd/yyy

Risk

factorsLocated Origin

Previous

Positive

TST

Date read

mm/dd/yyyy

Result

(+ or -)

Date read

mm/dd/yyyy

Result

(+ or -)

Date

mm/dd/yyyy

Result

(coded)

Date taken

mm/dd/yyyy

Result

(coded)Started?

Complet

ed?

Sympto

matic ?Comments

IDENTIFIED CONTACTS - LINE LIST

Culture :

Sensitivities :

AFB smear :

GROUP SCREENED

Specimen type:Non-Resp

Symptom onset date:

CXR:

Total infectivity rating:

SputumCXR ProphylaxisSkin Test at < 8

Weeks

Skin Test at >8

Weeks

Click here to sort by

CSPT Evaluation

Page 38: Tuberculosis: key issues for IPAC

CSPT: Section 1

3

Page 39: Tuberculosis: key issues for IPAC

Hospital Updates

• Limited literature in hospital settings

• Community-based settings

• Four studies on specific exposure times required for transmission

• Average exposure time to a highly infectious case (cavitary, smear +) for transmission to occur = 360 cumulative hours

Close Non-Household (CNHH) Low High

Contacts >5 years 120+ hours 96+ hours

Immunosuppressed, contacts <5 years 60+ hours 36+ hours

Page 40: Tuberculosis: key issues for IPAC

Updated Hospital Guidelines

Low High

Patients with ≥48 hours cumulative exposure in the same room, or for larger bay areas the patients in adjacent beds, or participation in patient group activities (e.g. pediatric play room, psychiatric group programs) – TST > 8 weeks BIC, unless <5 years old, initial & repeat TST Staff with direct patient care for ≥60 hours cumulative exposure; all staff involved during cough inducing/aerosolizing procedures if not wearing PPE – TST > 8 weeks BIC

Patients with ≥ 24 hours cumulative exposure in the same room, or participation in patient group activities (e.g. pediatric play room, psychiatric group programs) – TST > 8 weeks BIC, unless <5 years old, initial & repeat TST Staff with direct patient care ≥ 36 hours cumulative exposure; all staff involved during cough inducing/aerosolizing procedures if not wearing PPE – TST > 8 weeks BIC

Immunosuppressed contacts: Examples of immunosuppressed contacts include HIV positive with low CD4 counts; dialysis, oncology, and transplant patients. Consider lowering threshold based on extent of immunosuppression and closeness of exposure (e.g. direct caregivers). Consider symptom assessment and chest x-ray with or without TST, and flag TB exposure in the client's hospital/physician chart.

Page 41: Tuberculosis: key issues for IPAC

CSPT: Section 3

Emergency Medical Services

• notify to keep in the loop, along with any follow-up recommendation

Public travel (new!)

• no follow-up for local transit

• only consider for long distance travel if evidence of transmission among closer contacts; for air travel, continue to use PHAC guidelines

Wound care (new!)

• only follow-up staff who were involved in high pressure irrigation of open TB wounds that are smear AND culture positive AND were not wearing an N95 mask

Page 42: Tuberculosis: key issues for IPAC

Adapting the parameters

• Assess size of room and ventilation: if tiny and stuffy, lower hours of exposure threshold (and the opposite!)

• Beware of lunchrooms and outdoor smoking sites

• Babies and toddlers: lower hours of exposure based on closeness/care-giving

• 120 hours is not magically different from 116 hours – use judgement and consider operational factors

• For individual contacts, add up their exposure in multiple settings

• Always evaluate contact investigation outcomes for each case – expand contact follow-up? Using what new parameters?

Page 43: Tuberculosis: key issues for IPAC

Follow-up processes – ideally…

• Public Health, IPAC and OccHealth

collaborate to identify patient, visitor, staff

contacts meeting applied CSPT criteria

• Meetings to coordinate complex follow-up

(e.g. NICU, hemodialysis, oncology)

• Community and hospital contact results

pooled to decide if expansion needed

Page 44: Tuberculosis: key issues for IPAC

Occ Health TB programs

Baseline TST

Annual repeat TST for high

risk settings (ER, general

medicine, lab, etc)

Contact follow-up for specific

TB exposures

Page 45: Tuberculosis: key issues for IPAC

Occ Health: TB prevention

Every hospital screens staff for TB

Every positive TST screen is a chance to

discuss LTBI treatment…and prevent HCW

TB

On-line TST interpreter: http://tstin3d.com/

Page 46: Tuberculosis: key issues for IPAC

Using it outside Toronto

• CSPT was developed and evaluated based on use in the Toronto context – urban, high proportion of foreign-born with high baseline TST positivity, Toronto built environment

• Hospital recommendations will work best in context of a good occ health TB program and measured air exchange rates

• Want a copy of the tool and documentation?

[email protected]

416-338-7600

Page 47: Tuberculosis: key issues for IPAC

Questions?

Questions?

Dr Elizabeth Rea Toronto Public Health TB Program

416-525-3794 416-338-7600

[email protected] [email protected]

Page 48: Tuberculosis: key issues for IPAC

Type of Follow-up

• TB symptom assessment should be done for EVERYONE and if anyone is symptomatic, collect sputum.

• For most settings (household, CNHH, schools and daycares and shelters) initial & repeat TST

• In most other settings, or if the first opportunity for testing is close to the 8 week mark – post 8 week TST is sufficient

• Elderly clients, immunosuppressed and LTCF – include symptom assessment and chest x-ray and flag the patient’s file; only do a TST if LTBI treatment is an option

• Children <5 years should always have an initial and repeat TST with medical assessment and window prophylaxis, in any setting